Antimicrobial Resistance Diagnostics Market is expected to reach USD 6.7 billion by 2031

Antimicrobial Resistance Diagnostics Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the antimicrobial resistance diagnostics market will expand from USD 4.8 billion in 2026 to USD 6.7 billion in 2031 at a CAGR of 6.9% during the forecast period.

Rising cases of drug-resistant infections worldwide are rapidly driving demand for antimicrobial resistance diagnostics. The rise in the number of bacteria, fungi, and other pathogens resistant to multiple drugs has increased the stress on healthcare systems all over the globe and led to the need for new, advanced diagnostic d evices that can detect resistance mechanisms even in the early stages. In this way, governments, healthcare bodies, and international health agencies are putting in a lot of resources into the programs related to the prudent use of antimicrobials and in the surveillance of AMR, which are the major factors pushing the growth of this market. Also, improvements in molecular diagnostics, polymerase chain reaction (PCR), next-generation sequencing (NGS), mass spectrometry, and rapid point-of-care testing are revolutionizing the diagnostic environment by allowing the identification of resistant pathogens at a much quicker rate than the traditional culture-based methods.

Request a free sample copy or view the report summary: Antimicrobial Resistance Diagnostics Market Report

Antimicrobial Resistance Diagnostics Market Report Highlights

• Among Antimicrobial Resistance Diagnostics Market, the Kits & Reagents segment is set to grow at the fastest pace since diagnostic testing volumes are rising, and molecular-based assay instruments are increasingly being adopted by clinical labs and hospitals. A major driver of the segment is the increasing need for consumables that enable quick, accurate, and user-friendly identification of pathogens and determination of resistance profiles. Kits and reagents are indispensable parts of PCR, NGS, immunoassay, and microarray testing protocols, resulting in regular demand in both healthcare and research environments. Besides that, the ongoing creation of targeted reagent panels for multidrug-resistant organisms, the rising number of infectious disease surveillance programs, and the broadening of decentralized diagnostic testing are the most important factors behind the vigorous market expansion of this segment.

• NGS (Next-Generation Sequencing) is predicted to see the biggest increase in growth over other sections, as it can deliver full genomic analysis and give very detailed antimicrobial resistance profiles. The main advantage of NGS is the ability to quickly and specifically identify resistance genes, mutation patterns, and new pathogens, which adds to its popularity in clinical diagnosis, epidemiological studies, and research. Besides, more funding for precision medicine, price reduction of sequencing, and more use of bioinformatics and AI in genomic analytics are some of the factors leading to more use of NGS platforms.

• The fastest growth in the market is expected from the Epidemiological Surveillance segment as countries around the world increase their efforts to monitor and contain the spread of antimicrobial resistance. National and regional AMR surveillance programs are being rolled out by governments, public health agencies, and international organizations on a larger scale to identify resistant pathogens and shape public health responses.

• Rising infectious disease prevalence, increasing antibiotic misuse, and expanding healthcare infrastructure are accelerating market growth across Asia-Pacific.

Antimicrobial Resistance Diagnostics Market Growth Drivers and Restraints

Growth Drivers:

• Rising Prevalence of Antimicrobial-Resistant Infections: Increasing cases of antimicrobial-resistant infections are driving strong demand for rapid diagnostic technologies. The main cause of the increase in multidrug-resistant organisms has been the overuse and misuse of antibiotics in human health care, agriculture, and animal husbandry.

• Growing Demand for Rapid and Accurate Diagnostic Technologies: Healthcare providers are increasingly adopting advanced diagnostic technologies to improve treatment accuracy and reduce diagnostic turnaround times. Such advanced technologies yield faster and more reliable results than conventional culture-based methods. Molecular diagnostics, PCR-based assays, next-generation sequencing, and mass spectrometry allow for quick identification of pathogens and resistance genes, thus cutting down the diagnostic turnaround time and enhancing patient care.

Restraints:

• High Cost of Advanced Diagnostic Systems: High costs associated with advanced diagnostic instruments and molecular testing platforms continue to limit market penetration in developing regions. Many healthcare facilities, particularly in developing and low-income regions, face budget limitations that restrict the adoption of sophisticated AMR diagnostic technologies.

Antimicrobial Resistance Diagnostics Market Key Development

• Collaboration: In July 2025, Centre for Cellular and Molecular Platforms (C-CAMP), in collaboration with the International Centre for Antimicrobial Resistance Solutions (ICARS), introduced the One Health AMR Challenge 2025 with the goal to find, aid, and extend innovative technologies addressing Antimicrobial Resistance (AMR) in human, animal, and environmental health.

• Collaboration: In June 2025, the University of Ghana hosted global and regional healthcare leaders to strengthen innovation, implementation, and equitable access to AMR diagnostics. The meeting, organized by The Fleming Initiative, GARDP, and FIND, lasted two days and included several sessions led by experts where topics such as access to diagnostics, innovation, policy, data use, and market shaping were discussed.

Antimicrobial Resistance Diagnostics Market Segmentation

Knowledge Sourcing Intelligence has segmented the antimicrobial resistance diagnostics market based on application, product type, technology, and region:

Antimicrobial Resistance Diagnostics Market, By Product Type

• Instruments

• Kits & Reagents

• Software & Services

Antimicrobial Resistance Diagnostics Market, By Technology

• Polymerase Chain Reaction (PCR)

• Next-Generation Sequencing (NGS)

• Microarray

• Mass Spectrometry

• Immunoassays

Antimicrobial Resistance Diagnostics Market, By Application

• Clinical Diagnostics

• Drug Discovery

• Epidemiological Surveillance

Antimicrobial Resistance Diagnostics Market, By Region

• North America

  • USA

  • Canada

  • Mexico

• Europe

  • United Kingdom

  • Germany

  • France

  • Spain

  • Others

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Indonesia

  • Thailand

  • Others

• South America

  • Brazil

  • Argentina

  • Others

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • Others

Antimicrobial Resistance Diagnostics Market Key Players

• Thermo Fisher Scientific

• Roche Diagnostics

• Bio-Rad Laboratories

• QIAGEN

• Danaher Corporation

• Abbott Laboratories

• bioMérieux

• Bruker Corporation

• Accelerate Diagnostics

• Hologic